Clinical trials
Phase 3 Glomerulonephritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Alpine Immune Sciences Inc, A Subsidiary of Vertex | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Chinese University of Hong Kong | 1 |
| Ewha Womans University | 1 |
| Hamad Medical Corporation | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| Kasr El Aini Hospital | 1 |
| Leiden University Medical Center | 1 |
| National Taiwan University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis | 15 |
| Glomerulonephritis, IGA | 8 |
| Kidney Diseases | 7 |
| Renal Insufficiency, Chronic | 6 |
| Urologic Diseases | 5 |
| Proteinuria | 4 |
| Nephritis | 3 |
| Autoimmune Diseases | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Lupus Nephritis | 2 |
Trials
Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.